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Abstract Campylobacter jejuni is the most frequent
cause of human food-borne bacterial gastroenteritis but its
physiology and biochemistry are poorly understood. Only a
few amino-acids can be catabolised and these are known to
be important for host colonization. Here we have estab-
lished methods for rapid high throughput analyses of global
metabolism in C. jejuni using direct injection mass spec-
trometry (DIMS) to compare metabolite fingerprints of
wild-type and mutant strains. Principal component analyses
show that the metabolic fingerprint of mutants that have a
genomic deletion in genes for key amino-acid catabolic
enzymes (either sdaA, serine dehydratase; aspA, aspartase
or aspB, aspartate:glutamate transaminase) can easily be
distinguished from the isogenic parental strain. Assignment
of putative metabolites showed predictable changes
directly associated with the particular metabolic lesion in
these mutants as well as more extensive changes in the
aspA mutant compared to the sdaA or aspB strains. Further
analyses of a cj0150c mutant strain, which has no obvious
phenotype, suggested a role for Cj0150 in the conversion of
cystathionine to homocysteine. Our results show that
DIMS is a useful technique for probing the metabolism of
this important pathogen and may help in assigning function
to genes encoding novel enzymes with currently unknown
metabolic roles.
Keywords Campylobacter jejuni  DIMS  Metabolism 
aspA  aspB  sdaA
1 Introduction
Campylobacter jejuni is the leading cause of human bac-
terial gastroenteritis in the western world (Scallan et al.
2011) with over 400 million reported cases each year world
wide (Ruiz-Palacios 2007), resulting in a large economic
burden (Batz et al. 2012). The bacterium is commensal in
the intestines of chickens and most infections arise from
consumption of contaminated poultry meat. The physiol-
ogy and metabolism of C. jejuni is less well understood
compared to other food-borne pathogens. A limited ability
to metabolise sugars along with the absence of phospho-
fructokinase (Parkhill et al. 2000) results in a major
requirement for non-carbohydrate derived carbon sources
in C. jejuni (Velayudhan and Kelly 2002). Previous studies
have shown that only a limited range of amino acids and
certain TCA cycle intermediates, are important carbon
sources for C. jejuni (Velayudhan et al. 2004; Guccione
et al. 2008; Hofreuter et al. 2008). The ability to use
aspartate, glutamate (Leon-Kempis et al. 2006; Guccione
et al. 2008), serine (Velayudhan et al. 2004; Hofreuter et al.
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2012) and proline (Guccione et al. 2008; Hofreuter et al.
2008, 2012) is characteristic of most strains, with muta-
tions in aspA (aspartase) aspB (aspartate:glutamate ami-
notransferase) and sdaA (serine dehydratase) genes found
to result in an inability to catabolise these amino acids and
defects in the colonisation of chicken and mouse animal
models (Velayudhan et al. 2004; Guccione et al. 2008;
Hofreuter et al. 2008, 2012).
Global metabolomic approaches have not previously
been used to study the central carbon metabolism of C.
jejuni. Although nuclear magnetic resonance methods
have been used for this type of application (e.g. Raams-
donk et al. 2001), sensitivity of metabolite detection
remains an issue. A potentially useful technique that has
previously been used for high throughput fingerprinting is
automated electrospray ionisation time of flight mass
spectrometry (ESI-TOF MS) (Dunn et al. 2005). ESI-TOF
MS is a method that enables rapid sample runtime and
relatively simple mass spectra for complex samples, albeit
at the expense of accurate mass identification and quan-
tification (Dunn et al. 2005). Although originally utilised
for high-throughput clinical screening there have also
been several microbial applications of this technique,
often in bacterial strain discrimination (Goodacre et al.
1998; Vaidyanathan et al. 2001), including MALDI-TOF
mass spectrometry based identification of Campylobacter
species (Besse`de et al. 2011). The possibility of utilising
Direct Injection ESI-TOF MS (DIMS) as a means of
rapidly analysing gene knockout mutant libraries has also
been suggested, with the major advantage of minimal
sample preparation and processing. Work by Kaderbhai
et al. (2003) found DIMS to be capable of discriminating
between tryptophan metabolism mutants in Escherichia
coli and ESI-TOF MS has been suggested as an advan-
tageous methodology for assigning unknown gene func-
tion (Castrillo et al. 2003).
In this study, previously described C. jejuni null mutants
in aspA, aspB (Guccione et al. 2008) and sdaA (Velayud-
han et al. 2004) have been analysed by DIMS in order to
assess whether the metabolic lesions in these strains can be
confirmed by their metabolic fingerprints and whether
other changes in the metabolome can be inferred from
putative metabolite identifications. The relative abundances
of key metabolites have been found to show the changes
expected in these mutants and the techniques have also
been applied to a mutant in cj0150c (Guccione et al. 2008),
a gene of unknown function, to generate a hypothesis for
the role of the encoded aminotransferase enzyme, Cj0150.
Our results suggest that non-targeted, high sensitivity, low
mass accuracy direct injection techniques can be useful for
probing the metabolism of poorly understood pathogens
like C. jejuni and for generating hypotheses for the func-
tion of genes with currently unknown roles.
2 Materials and methods
2.1 Bacterial strains, media and growth conditions
The strains used in this study were C. jejuni NCTC 11168
wild-type and a set of isogenic mutants carrying null
mutations in the sdaA, aspA, aspB and cj0150c genes.
These mutants have been fully described in previous pub-
lications (Velayudhan et al. 2004; Guccione et al. 2008)
and were constructed by the insertion of antibiotic resis-
tance cassettes into the appropriate genes. The mutants
were obtained from the Kelly lab culture collection and
verified by PCR analysis with gene specific primers. All
bacterial strains were routinely grown on Columbia agar
containing 5 % (v/v) lysed horse blood and 10 lg mL-1
amphotericin B and vancomycin at 37 C under micro-
aerobic conditions [10 % (v/v) O2, 5 % (v/v) CO2 and
85 % (v/v) N2] in a MACS growth cabinet (Don Whitley
Scientific, Shipley, UK). For mutant strain analysis five
biological replicate cultures were grown alongside five
biological replicates of the isogenic parent strain in 25 mL
volumes of brain heart infusion (BHI) (Oxoid) containing
5 % (v/v) foetal calf serum (FCS; GIBCO) under micro-
aerobic conditions with continuous shaking at 180 rpm.
2.2 Extraction of C. jejuni metabolites
Cells taken for metabolite extraction were harvested by
centrifugation (15,871 g, 1 min, 20 C), the supernatants
removed and the cell pellets flash frozen in liquid nitrogen.
This decreased the possibility of cell lysis resulting in
metabolites entering the supernatant and hence increased
the number of measureable metabolites within the cells.
Cell density was normalised by OD600 and centrifugation
of a culture volume that would correspond to 1 mL of
OD600 1.0 culture. Metabolite extraction was performed
based on the method of Overy et al. (2005). Cell pellets
were re-suspended in 1 mL methanol:chloroform 1:1
(-20 C) and vortexed to disrupt the pellet. Samples were
then stored at -80 C for 1 h before further disruption
through vigorous shaking with cold chloroform:methanol
(1:1) washed stainless steel ball bearings (2 mm diameter).
Samples were again stored at -80 C for 1 h before the
addition of 400 lL ice-cold ultra high pure (UHP) water.
Tubes were mixed by vortexing before centrifugation (15,
8719g, 1 min, 4 C) whereafter the top aqueous phase
(methanol plus water) containing mainly polar metabolites
was decanted into a new cooled 1.5 mL plastic tube. Then
400 lL ice-cold UHP water was added to the chloroform
(organic) phase containing mainly non-polar metabolites
and centrifuged (15, 8719g, 1 min, 4 C). The top aqueous
phase was again decanted into the 1.5 mL plastic tube
containing the previously harvested aqueous phase. Both
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aqueous and organic phases were then stored at -80 C
until analysis. A negative control of the above full har-
vesting and extraction procedure was carried but without
the addition of bacteria. The metabolite profiles of these
negative controls were outliers in the subsequent PCA
analysis (data not shown).
2.3 Electrospray ionisation time of flight mass
spectrometry (ESI-TOF MS)
ESI-TOF MS was performed on a LCT spectrometer
(Waters Ltd, Manchester, UK) based on the methods
described in Davey et al. (2008) and Walker (2011). Data
acquisition and processing was performed on MassLynx
(version 4) to create centroid peak lists (m/z accurate to 4
decimal places vs. ion counts), which were then transferred
to Microsoft Excel (Microsoft Corp, USA) as text files. The
mass spectrometer was operated at a resolution of 4,000
(FWHM) at mass 200 m/z in positive and negative ion
modes at a capillary voltage of 2,800 V (positive) and
2,500 V (negative), extraction cone at 3 V and sample
cone at 20 V with a rangefinder lens voltage of 75 V
chosen for detection of masses from 50 to 800 Da. Source
temperature was 110 C and desolvation temperature was
120 C. Flow rates were 100 L h-1 for nebulisation and
400 L h-1 for desolvation. Spectra were collected in cen-
troid mode at a rate of one spectrum s-1 (0.95 s scan time,
0.05 s interscan delay) with 180 summed over a 3-min
period before being exported without background sub-
traction or smoothing.
Samples were either loaded using a syringe pump (Ra-
zel, Connecticut, USA) at a flow rate of 20 lL min-1
(organic phase) or loaded using an automated Waters 2695
Separations Module combining a HPLC pump and an
autosampler (Waters, Hemel Hempstead, UK) (aqueous
phase) with an inject volume of 100 lL at a flow rate of
50 lL min-1. A LocksprayTM interface was used to give
an external standard and allow automated correction of
mass measurements (5 ng lL-1 sulphadimethoxine giving
a lockmass of 309.0653 or 311.0814 for negative and
positive modes respectively). Samples were analysed in a
randomised order to minimize effects of day-to-day
machine variation.
2.4 Data processing
For each sample run, the summation of 180 centroid mode
spectra were exported from MassLynx data systems as text
file peak lists (Accurate mass to 4 decimal places vs. ion
count). These were imported into Microsoft Excel
(Microsoft Corp, USA) and an in-house macro programme
(created by Prof. Mike Burrell, Sheffield University, UK)
used to compare the accurate masses of three technical
replicate analyses of each sample. The accepted range to
give the maximum number of peaks with minimum false
positives was proposed by Overy et al. (2005) to be defined
best by plotting the acceptable mass variance as a linear
function of the m/z values. The same equations were used:
positive mode, y \ 0.00003x ? 0.0033; for negative mode
y \ 0.00003x ? 0.044 where y is the standard deviation of
the three masses and x is the mean of the three masses.
Those masses found to have a y value within acceptable
limits had their mean accurate mass and mean response (as
% total ion count in order to minimize sample–sample
variation and normalize data sets) exported to a separate
table. This methodology negated the need for a noise
threshold and enabled true low intensity metabolite peaks
to be kept. principal component analysis (PCA) was carried
out using Pareto scaled 0.2 Da binned data sets in Simca-P
v12.0 software (Umetrics, Sweden). Significance values of
the ion counts between the samples were determined using
two-tailed t tests.
2.5 Putative metabolite identification
Preliminary identification of metabolites was performed
through the comparison of monoisotopic masses likely to
be present in extracts, including [M?H]?, [M-H]- and
[M?Na]? against the list of metabolites in the biocyc
database (http://biocyc.org/) and to a subset of metabolites
within biocyc predicted to be present in C. jejuni NCTC
11168 (http://biocyc.org/CJEJ192222/class-tree?object=
Compounds) based on the genome annotation, to an
accuracy of 0.2 Da (Davey 2011).
3 Results and discussion
3.1 Direct injection ESI-TOF MS methodologies can
distinguish C. jejuni metabolomic profiles
Methodology for both the quenching of metabolism and
extraction of metabolites is still a controversial area and
can require significant optimisation for individual organ-
isms to yield reproducible data (Meyer et al. 2013). Many
studies have looked at the effectiveness of quenching and
extraction techniques through statistical methods (Bolten
et al. 2007; Faijes et al. 2007). However, very few have
been focussed on the ability to see biologically relevant
metabolite changes within a non-targeted metabolomics
analysis as a measure of quenching and extraction effec-
tiveness. A variety of quenching techniques have been
adopted for bacterial metabolomics, with the most popular
methods being quenching in cold organic solvents, fol-
lowed by centrifugation and extraction (Bolten et al. 2007)
or rapid filtration based methods, although metabolite
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leakage problems are still an issue. Agar plate membrane
filter culture techniques followed by rapid solvent
quenching is one solution for these problems (Bennett et al.
2008).
In this study, a complex liquid medium (BHI-FCS) was
used for bacterial cultivation to ensure as similar growth as
possible of wild-type and mutant strains as well as main-
taining activity of amino-acid catabolic routes. The use of a
simple centrifugation step to collect the cells meant a
methodology could be employed that resulted in no
metabolite loss, through the freezing of whole cell pellets
in liquid nitrogen (Bolten et al. 2007) before solvent
extraction. Although even brief centrifugation may cause
some metabolic perturbation, the effects should be mini-
mised when directly comparing wild-type and mutant cell
metabolomes, as both sample groups are treated identi-
cally. Similarly, washing steps were avoided to prevent
metabolite loss but contamination of cell pellets with
residual medium will be the same for each sample com-
pared and medium-only controls were also run. Although
the efficiency of extraction techniques is organism specific
(Faijes et al. 2007; Meyer et al. 2013), comparative studies
Fig. 1 Principal component analysis (PCA) of C. jejuni NCTC 11168
and amino acid catabolism mutant strains. Metabolite levels in
multiple replicates of C. jejuni NCTC 11168 and aspB strains were
analysed by ESI-TOF MS in positive and negative ionisation mode
and processed so that centroid m/z peaks were converted to text file
peak lists and placed into 0.2 Da bins. Principal component analysis
was performed on these bin lists. PCA plot a and b show analysis of
positive and negative ionization datasets respectively for C. jejuni
NCTC 11168 (filled circles) and aspA (open circles). PCA plot
(c) and (d) show analysis of positive and negative ionization datasets
respectively for C. jejuni NCTC 11168 (filled circles) and aspB (open
circles). PCA plot (e) and (f) show analysis of positive and negative
ionization datasets respectively for C. jejuni NCTC 11168 (filled
circles) and sdaA (open circles). In all instances mutant strains were
observed to group separately from their isogenic parent strain
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have shown cold methanol based methodologies to be
among the most efficient for extracting a wide range of
metabolites, in a broad spectrum of bacteria (Maharjan and
Ferenci 2003; Park et al. 2012). For this reason a cold
methanol:chloroform based extraction protocol was adop-
ted here (adapted from Overy et al. (2005)).
Multiple replicates of aspA, aspB and sdaA mutant
extracts were analysed by ESI-TOF MS alongside extracts
from the C. jejuni NCTC 11168 isogenic parent strain in
both negative ionisation mode (to focus on detecting car-
boxylic acids and alcohols) and positive ionization mode
(to focus on detecting amines). Background noise was
removed by selecting peaks whereby mass variance
between three technical replicates fell within an accepted
range and data was normalized to the total ion count before
being separated into 0.2 Da mass unit bins (Online
resources 1 and 2). PCA can clearly be seen to separate
mutant profiles from their isogenic parent strain (Fig. 1).
Positive ionization datasets, containing a larger number of
ionization species, could be separated in a similar fashion
to negative ionization datasets.
3.2 Allocation of putative metabolite identities
to the C. jejuni metabolome
Dunn et al. (2005) have previously shown DIMS methods
to be capable of identifying metabolites of the same
nominal but different monoisotopic mass. In our work,
protocols were adapted to minimize problems of frag-
mentation and ion suppression as previously highlighted
(Dunn et al. 2005) and putative metabolite identities were
preferentially assigned to negative ionization data due to
the existence of fewer likely ionic species [M-H]-. A full
list of m/z bin allocations and the associated metabolite
identities can be seen in Online resources 1–3.
It has been stated that bacterial metabolomes contain
low numbers of metabolites, i.e. *600 predicted for E. coli
and Saccharomyces cerevisiae (Wang et al. 2006) and 467
in a recent metabolic model of C. jejuni metabolism
(Metris et al. 2011). Clearly a reliance on genomic analysis
to make predictions (Oliver et al. 1998; Metris et al. 2011)
will underestimate metabolome complexity, with many
enzymes likely to work on broader substrate ranges within
the cell than generally accepted, and many genes with
unknown metabolic roles. In our work, the large metabolite
list from the biocyc database has been used to maximise
allocated peak identities. However, this obviously may
result in metabolites being allocated that do not lie within
predicted metabolic routes of C. jejuni. We therefore also
present metabolite tables in Online resources 1–3 based
only on a comparison with predicted metabolites in C. je-
juni NCTC 11168 as derived from the automated genome
annotation. It is essential that putative metabolite
allocations relating to changes of interest are thoroughly
reviewed and should be confirmed in future work by other
targeted assays.
3.3 Putative metabolite identification in characterised
metabolic mutants is consistent with known blocks
in metabolism
Serine dehydratase catalyses the deamination of serine to
form pyruvate and ammonium ions, in the first step of
serine catabolism. In replicate extracts of the sdaA mutant
compared to the wild-type, analyzed in negative ion ioni-
sation mode, m/z 104.00, putatively corresponding to ser-
ine, was found to have undergone a 4.5 fold increase from
0.083 ± 0.016 to 0.37 ± 0.03 % of the total ion count with
a p value of 8.2 9 10-7 (Fig. 2). Other key m/z values
corresponding to metabolites of central metabolism within
and connected with the citric-acid cycle were found to be
highly similar with only m/z 117.00 (succinate) showing a
statistically significant decrease in the mutant strain
(Fig. 2). These results are consistent with the enzymatic
block in the sdaA mutant resulting in a build-up of serine
relative to wild-type. In total, however, we found only
about 4.3 % of the total negative ion metabolite bins were
significantly changed in the sdaA mutant (Table 1 and
Online resource 1). The lack of other major central
metabolite changes in this mutant is consistent with the
only major effect on cell physiology being lack of growth
on L-serine as C-source in minimal media (Velayudhan
et al. 2004; Guccione et al. 2008). The fact that aspartate,
proline and glutamate can still be utilised as carbon sources
Fig. 2 Key metabolite differences between C. jejuni NCTC 11168
and sdaA strains. Following ESI-TOF MS of five biological replicates
in negative ionisation mode, m/z peaks were assigned putative
metabolite identities to an accuracy of 0.2 Da for C. jejuni NCTC
11168 (black bars) and sdaA strains (open bars). Shown are those
metabolites detected that are most closely related to amino-acid
catabolism [Ser serine (104.00); Pyr pyruvate (87.00); Oxo 2-oxo-
glutarate (145.00); Suc Succinate (117.00); Fum Fumarate (115.00);
Mal Malate (133.00); Oxa oxaloacetate (134.00); PEP phosphoenol-
pyruvate (167.00); Asp aspartate (132.00); Glu glutamate (146.00);
Pro proline (115.00); Gln glutamine (145.00)] as a % of the total ion
count. *p value\0.05 between C. jejuni NCTC 11168 and sdaA strain
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and that no growth defect is observed in complex media
(Velayudhan et al. 2004) may explain why pyruvate levels
are also maintained.
The metabolite profile of the aspA mutant was found to
be distinctly different, with significant changes in the rela-
tive abundance of a much larger number of metabolites
(Table 1 and Online resource 2), indicating a large-scale
disruption to central as well as more peripheral metabolism.
Aspartase catalyses the deamination of aspartate to fuma-
rate plus ammonium ions and analysis of the metabolite
levels show a relative accumulation of m/z 146.00 (gluta-
mate) and m/z 132.00 (aspartate), and significantly reduced
levels of m/z 115.00 (fumarate) and several putative TCA
cycle metabolites, consistent with the metabolic lesion in
this mutant (Fig. 3). An interesting exception is m/z 145.00
(2-oxoglutarate) (0.30 ± 0.02 and 0.30 ± 0.02 % total ion
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Fig. 3 The effect of an aspA null mutation on central carbon
metabolism. Metabolites in black typeface show an increase in
relative abundance in the aspA mutant; white typeface a decrease in
relative abundance; grey typeface no change and italicized typeface,
not detected in either strain. *p value \0.05 between the C. jejuni
NCTC 11168 (black bars) and aspA strain metabolite levels (open
bars), displayed as a % of the total ion count with bin values depicted
above. Aspartate and glutamate are 10.5 and 12.6 fold increased
respectively in the aspA strain compared to the wild-type. Most
central metabolites are lower in relative abundance in the aspA strain,
exceptions being 2-oxoglutarate, a glutamate precursor, malate and
citrate
Table 1 Proportion of metabolite bins changed in each of the mutant
strains analysed in this study, compared to the isogenic wild-type
parent strain
Strain Ionisation
mode
Total
metabolite
count
Significantly
changed
%
Metabolites
changed
sdaA - 2,167 94 4.34
aspB - 2,171 135 6.22
aspA - 1,568 278 17.73
cj0150c - 2,060 267 12.96
sdaA ? 1,474 72 4.88
aspB ? 1,532 135 8.81
aspA ? 1,568 223 14.22
The table shows how many bins have a value in at least one replicate
and how many of those are significant at p \ 0.05 when comparing
each mutant with the wild-type strain
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count in NCTC 11168 and aspA mutant respectively), but
this cannot be distinguished from glutamine from our ana-
lysis. The many metabolite changes are consistent with the
known phenotype of the aspA mutant, which cannot grow
on aspartate, glutamate or proline and has a reduced growth
rate compared to the wild-type, even in complex media
(Guccione et al. 2008).
AspB in C. jejuni is encoded by cj0762c and is essential for
growth on glutamate, as it converts glutamate to aspartate
using oxaloacetate as the amino-acceptor. In the aspB mutant
a significant accumulation of m/z 146.00 (glutamate) is
observed preceding the metabolic lesion as well as a signifi-
cant increase in m/z 145.00 (2-oxoglutarate). Compared to the
aspA mutant, fewer metabolites overall were significantly
changed (Table 1 and Online resources 1 and 2). However,
several glutamate precursors in various metabolic pathways
have undergone significant changes (Fig. 4), which are not
readily interpretable but might, for example, result from
changes in enzyme allosteric control.
Analyses of these previously characterised metabolic
mutants clearly shows that a simple ESI-TOF direct injection
method is capable of detecting the corresponding metabolic
lesion and provides unique information about how the
mutation is affecting the wider metabolome (Online resour-
ces 1 and 2). Removal of AspA (by mutation) from the highly
interconnected cellular enzyme network clearly has a ‘‘ripple
effect’’ that spreads far beyond the mutant metabolic lesion.
This has been observed in some other bacterial metabolic
mutant studies [for a recent example see Lee et al. (2014)].
The observed metabolite changes will be the combined result
of many processes e.g. altered allosteric control of enzyme
activities by key metabolites and changed expression of
enzyme encoding genes as a result of altered activity of
regulatory proteins. It would therefore be highly informative
to correlate mutant metabolomic data with transcriptomic
and proteomic data to provide an integrated view that might
give insights into the types of mechanisms involved.
3.4 Analysis of a cj0150c mutant reveals a possible
role for Cj0150 as a cystathionine b lyase
In contrast to SdaA, AspA and AspB, Cj0150 is an enzyme
of unknown function. Sequence analysis shows that it is a
member of the amino-acid aminotransferase type I family
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Fig. 4 The effect of an aspB null mutation on glutamate metabolism.
Having putatively identified metabolites from ESI-TOF MS negative
ionisation mode the relative metabolite levels were analysed related to
the lesion in metabolism caused by aspB mutation (black cross).
Metabolites in black typeface show an increase in relative abundance
in the aspB strain and in grey typeface a decrease. *p value \ 0.05
between the C. jejuni NCTC 11168 (black bars) and aspA strain
(white bars) metabolite levels, displayed as a % of the total ion count.
Glutamate can be seen to have undergone a significant sevenfold
increase and aspartate a slight decrease in the aspB mutant. Many
metabolites linked to glutamate can be seen to have undergone an
increase in the aspB strain
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(Guccione et al. 2008). These enzymes are known to be
active with a wide range of substrates but it is not possible
from sequence similarities alone to ascribe a physiological
function to them. Purified recombinant Cj0150 has previ-
ously been shown to have aspartate:glutamate amino-
transferase activity (Guccione et al. 2008), but this was not
thought to be physiologically significant as a cj0150c
mutant strain shows no growth defect on glutamate,
whereas a cj0762c (aspB) mutant is completely unable to
grow on or utilise glutamate or proline as a carbon source
(Guccione et al. 2008). Here, we compared the metabolic
fingerprints of the isogenic wild-type and cj0150c mutant
by DIMS. PCA analysis of the data show ESI-TOF MS
based metabolomics is capable of distinguishing the wild-
type and mutant strain, even though the latter has no
obvious growth or other known phenotype (Fig. 5). Ana-
lysis of the changes in the relative abundance of the
putatively identified metabolites, suggests that although the
cj0150c mutant is capable of growth on glutamate or pro-
line, it is in fact providing some level of aspartate:gluta-
mate aminotransferase activity in vivo as evidenced by a
small but significant change in the ratio of glutamate and
aspartate in the wild-type and mutant strains (Fig. 6). Most
interestingly, we noted larger significant changes in two
metabolites that we putatively identified as cystathionine
and homocysteine. Changes in cystathionine and homo-
cysteine levels would be consistent with Cj0150 being a
cystathionine b lyase. Cystathionine b lyases are PLP
dependent enzymes that function in the transulphuration
pathway of methionine biosynthesis, converting cystathi-
onine to homocysteine via an a/b elimination reaction
(Auger et al. 2005). Significantly, Guccione et al. (2008)
carried out a phylogenetic analysis of type I aminotrans-
ferases and found that Cj0150 clusters within the IX sub-
group, along with enzymes experimentally found to
possess cystathionine b lyase activity (Auger et al. 2005;
Chu et al. 1995). In addition, the gene immediately
downstream of cj0150c in strain NCTC 11168 encodes
homoserine dehydrogenase; an enzyme that functions to
produce homoserine from aspartate semialdehyde, an
intermediate in the methionine biosynthetic pathway. It is
important to note that C. jejuni does contain an annotated
metC gene (cj1393), the major cystathionine b lyase known
to perform this function (Lodha et al. 2010), and that
methionine levels were maintained in the cj0150c strain.
For this reason it is difficult to confidently predict whether
the cystathionine b lyase activity of Cj0150 would be
physiologically relevant for methionine biosynthesis, but
determination of the kinetics of this activity for purified
Cj0150 is clearly warranted. Although some changes in
other putative metabolites related to aminotransferase
activity were seen (tyrosine aminotransferase, phenylala-
nine aminotransferase; Fig. 6 and Online resource 3) the
extent of the changes were less convincing, compared to
those discussed above.
4 Concluding remarks
We have shown that DIMS fingerprints can separate met-
abolomic profiles of metabolic mutants of C. jejuni and
give insights into the degree to which the metabolome is
changed by specific enzymatic blocks. Although the ESI-
TOF MS based metabolomics method used here suffers
from a lack of mass accuracy its high sensitivity and high
throughput make it an ideal strategy for the initial analysis
of differences in a large number of cellular metabolites in
mutant screens. Information from the DIMS fingerprint of a
mutant with no obvious phenotype has also been used here
to suggest an in vivo activity for the Cj0150 enzyme.
Fig. 5 Principal component analysis of C. jejuni NCTC 11168 and
cj0150c strains from negative ionisation mode metabolite profiles.
Metabolite levels in multiple replicates of C. jejuni NCTC 11168 and
cj0150c strains were analysed by ESI-TOF MS in negative ionisation
mode and processed so that centroid m/z peaks were converted to text
file peak lists and placed into 0.2 Da bins. Principal component
analysis was performed on these bin lists. PCA plot (a) shows
analysis of negative ionisation data with principal component 1 (PC1)
against principal component 2 (PC2). C. jejuni NCTC 11168 and
cj0150c are represented as closed circles and open circles respec-
tively with the corresponding score loading plot shown in (b)
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